These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 18087769)
1. Proceedings from the International Symposium: Cannabinoids as New Tools for the Treatment of Neurological Disorders, March 2006, Madrid, Spain. Mol Neurobiol; 2007 Aug; 36(1):1-136. PubMed ID: 18087769 [No Abstract] [Full Text] [Related]
2. Preface: cannabinoids as new tools for the treatment of neurological disorders. Fernández-Ruiz J; Guzmán M; Ramos JA Mol Neurobiol; 2007 Aug; 36(1):1-2. PubMed ID: 17952644 [No Abstract] [Full Text] [Related]
3. Cannabinoids in the Treatment of Neurological Disorders. Devinsky O; Whalley BJ; Di Marzo V Neurotherapeutics; 2015 Oct; 12(4):689-91. PubMed ID: 26334724 [No Abstract] [Full Text] [Related]
4. Editorial (Thematic Issue: From Old Cannabinoids to Emerging New Synthetic Derivatives with Potential Therapeutic Application in Neurological Disorders). Malfitano AM Recent Pat CNS Drug Discov; 2016; 10(2):75. PubMed ID: 27875961 [No Abstract] [Full Text] [Related]
5. Proceedings of the International symposium on Endogenous Cannabinoids. Madrid, Spain, March 4-5, 1998. Life Sci; 1999; 65(6-7):573-736. PubMed ID: 10484712 [No Abstract] [Full Text] [Related]
6. [Testing the administration of cannabinoids in neurological diseases]. Ideggyogy Sz; 2005 May; 58(5-6):175-6. PubMed ID: 16021965 [No Abstract] [Full Text] [Related]
7. Cannabinoids in paediatric neurology. Dan B Dev Med Child Neurol; 2015 Nov; 57(11):984. PubMed ID: 26443475 [No Abstract] [Full Text] [Related]
9. Considerations for clinical trials to study cannabinoids in Canadian children with neurologic disorders. Kelly LE; Junker A CMAJ; 2018 Aug; 190(34):E1002-E1003. PubMed ID: 30150241 [No Abstract] [Full Text] [Related]
10. Clinical/Therapeutic Approaches for Cannabinoid Ligands in Central and Peripheral Nervous System Diseases: Mini Review. Fijał K; Filip M Clin Neuropharmacol; 2016; 39(2):94-101. PubMed ID: 26818043 [TBL] [Abstract][Full Text] [Related]
11. [Therapeutic use of cannabinoids in neurology]. Schwenkreis P; Tegenthoff M Schmerz; 2003 Oct; 17(5):367-73. PubMed ID: 14513344 [TBL] [Abstract][Full Text] [Related]
12. Building evidence on therapeutic efficacy and innovative mechanisms of cannabinoids in neurological disorders. Reddy DS Exp Neurol; 2023 Jun; 364():114390. PubMed ID: 37058950 [No Abstract] [Full Text] [Related]
13. Brain cannabinoid systems as targets for the therapy of neurological disorders. Consroe P Neurobiol Dis; 1998 Dec; 5(6 Pt B):534-51. PubMed ID: 9974182 [TBL] [Abstract][Full Text] [Related]
14. Structural basis of signaling of cannabinoids receptors: paving a way for rational drug design in controling mutiple neurological and immune diseases. Huang S; Xiao P; Sun J Signal Transduct Target Ther; 2020 Jul; 5(1):127. PubMed ID: 32694501 [No Abstract] [Full Text] [Related]
15. [Marihuana and cannobinoids as medicaments]. Tkaczyk M; Florek E; Piekoszewski W Przegl Lek; 2012; 69(10):1095-7. PubMed ID: 23421098 [TBL] [Abstract][Full Text] [Related]
16. [Potential applications of marijuana and cannabinoids in medicine]. Zdrojewicz Z; Pypno D; Cabała K; Bugaj B; Waracki M Pol Merkur Lekarski; 2014 Oct; 37(220):248-52. PubMed ID: 25518584 [TBL] [Abstract][Full Text] [Related]
17. Cannabis: old medicine with new promise for neurological disorders. Carter GT; Weydt P Curr Opin Investig Drugs; 2002 Mar; 3(3):437-40. PubMed ID: 12054093 [TBL] [Abstract][Full Text] [Related]
18. Recent developments in the therapeutic potential of cannabinoids. Corey S P R Health Sci J; 2005 Mar; 24(1):19-26. PubMed ID: 15895873 [TBL] [Abstract][Full Text] [Related]